✦ LIBER ✦

Battling Prostate Cancer with 5-Alpha-Reductase Inhibitors: a Pyrrhic Victory?

✍ Scribed by Richard M. Hoffman; Richard G. Roberts; Michael J. Barry

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 114 KB
Volume: 26
Category: Article
ISSN: 0884-8734
DOI: 10.1007/s11606-010-1622-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Morphological and hormonal changes in th

Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-Alpha reductase Inhibitor

✍ Prahalada, S.; Rhodes, L.; Grossman, S.J.; Heggan, D.; Keenan, K.P.; Cukierski, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 2 views

## BACKGROUND. In rats, the prostate is divided into three distinct lobes, and the lobes are dependent on androgens [testosterone (T) and dihydrotestosterone (DHT)] as trophic hormones. However, the reasons for the difference in the incidence of proliferative changes reported are not well-understo

Effect of early treatment of prostate ca

Effect of early treatment of prostate cancer with the 5α-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats

✍ Zaccheo, Tiziana; Giudici, Donata; di Salle, Enrico 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

## Background: Turosteride, a selective 5alpha-reductase inhibitor, was reported to be effective in inhibiting the growth of established tumors in the dunning r3327 rat prostatic carcinoma model. we evaluated the preventive effect of turosteride when administered during the latency period in this p